Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failure.

[1]  E. Bossone,et al.  Multiple hormone deficiency syndrome: a novel topic in chronic heart failure , 2018, Future science OA.

[2]  Akshay S. Desai,et al.  Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure. , 2016, Journal of the American College of Cardiology.

[3]  C. Polychronakos,et al.  Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency , 2016, Hormone Research in Paediatrics.

[4]  R. Napoli,et al.  Multiple hormone deficiencies in chronic heart failure. , 2015, International journal of cardiology.

[5]  J. Cleland,et al.  Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. , 2015, European heart journal.

[6]  A. Schally,et al.  Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival , 2014, Proceedings of the National Academy of Sciences.

[7]  P. Douglas,et al.  IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry. , 2014, International journal of cardiology.

[8]  K. Karason,et al.  GH and the cardiovascular system: an update on a topic at heart , 2014, Endocrine.

[9]  D. Leosco,et al.  Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. , 2014, JACC. Heart failure.

[10]  Harald Becher,et al.  Left Ventricular Ejection Fraction and Volumes: It Depends on the Imaging Method , 2013, Echocardiography.

[11]  R. Napoli,et al.  Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. , 2013, JACC. Heart failure.

[12]  G. Merriam,et al.  Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement , 2013, Front. Endocrinol..

[13]  P. Segers,et al.  Early and Late Systolic Wall Stress Differentially Relate to Myocardial Contraction and Relaxation in Middle-Aged Adults: The Asklepios Study , 2013, Hypertension.

[14]  J. Ketelslegers,et al.  Impact of growth hormone (GH) treatment on circulating Nt-proBNP concentrations and on cardiac function in adult GH-deficient patients , 2012, Scandinavian journal of clinical and laboratory investigation.

[15]  J. Danesh,et al.  B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies , 2009, Circulation.

[16]  J. Francis,et al.  The role of cardiovascular magnetic resonance imaging in heart failure. , 2009, Journal of the American College of Cardiology.

[17]  L. Saccá,et al.  Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  Jeffrey L. Anderson,et al.  Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings , 2009, Cardiovascular ultrasound.

[19]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[20]  L. Saccá.  Heart failure as a multiple hormonal deficiency syndrome. , 2009, Circulation. Heart failure.

[21]  A. Richards,et al.  B-type natriuretic peptides and echocardiographic measures of cardiac structure and function. , 2009, JACC. Cardiovascular imaging.

[22]  P. Saiviroonporn,et al.  Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study. , 2008, Journal of cardiac failure.

[23]  K. Klose,et al.  B-type natriuretic peptide and wall stress in dilated human heart , 2008, Molecular and Cellular Biochemistry.

[24]  S. Bao,et al.  The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.

[25]  Guido Iaccarino,et al.  Growth hormone prolongs survival in experimental postinfarction heart failure. , 2003, Journal of the American College of Cardiology.

[26]  S. Plein,et al.  Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady‐state free precession imaging sequences , 2003, Journal of magnetic resonance imaging : JMRI.

[27]  M. Anastasiou-Nana,et al.  Hormonal profile in patients with congestive heart failure. , 2003, International journal of cardiology.

[28]  D. Pennell,et al.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.

[29]  R. Napoli,et al.  Growth hormone corrects vascular dysfunction in patients with chronic heart failure. , 2002, Journal of the American College of Cardiology.

[30]  Jeroen J. Bax,et al.  Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. , 2001, The Journal of clinical endocrinology and metabolism.

[31]  Wolzt,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.

[32]  P. Kang,et al.  The conserved phosphoinositide 3‐kinase pathway determines heart size in mice , 2000, The EMBO journal.

[33]  E. Arvat,et al.  Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine. , 2000, European journal of endocrinology.

[34]  T. Voigtländer,et al.  Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. , 1999, Circulation.

[35]  M. Lomsky,et al.  A placebo-controlled study of growth hormone in patients with congestive heart failure. , 1998, European heart journal.

[36]  M. Elam,et al.  Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[37]  P. Poole‐Wilson,et al.  Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy , 1998, The Lancet.

[38]  M. Donath,et al.  IGF-I and bFGF differentially influence atrial natriuretic factor and alpha-smooth muscle actin expression in cultured atrial compared to ventricular adult rat cardiomyocytes. , 1997, Journal of molecular and cellular cardiology.

[39]  T. Hedner,et al.  Growth hormone improves cardiac function in rats with experimental myocardial infarction , 1997, European journal of clinical investigation.

[40]  P. Douglas,et al.  Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. , 1997, Journal of the American College of Cardiology.

[41]  J. Ross,et al.  Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. , 1996, Circulation.

[42]  B. Biondi,et al.  A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. , 1996, The New England journal of medicine.

[43]  R. Clark,et al.  Growth hormone improves cardiac performance in experimental heart failure. , 1995, Circulation.

[44]  M. Russo,et al.  Reversible dilated cardiomyopathy due to growth hormone deficiency. , 1992, Chest.

[45]  P. Sönksen,et al.  CARDIAC FAILURE RESPONDING TO GROWTH HORMONE , 1989, The Lancet.

[46]  C. Vogelmeier,et al.  Wall stress determines systolic and diastolic function--Characteristics of heart failure. , 2016, International journal of cardiology.

[47]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[48]  P. Chanson,et al.  Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[49]  D. Gardner,et al.  N ATRIURETIC P EPTIDES , 1998 .